Dr Moore discusses recent advancements in endometrial cancer in looking ahead to SGO 2025, particularly the use of immune checkpoint inhibitors with chemotherapy. She is excited to see further ...

Kathleen N. Moore, MD, discusses the exciting advancements in endometrial cancer treatment, particularly over the past 2 years, as she prepares for the 2025 Society of Gynecologic Oncology Annual ...

SGO is the maker of the Mistika finishing system used for the high frame rate postproduction of "The Hobbit." By Carolyn Giardina Tech Editor AMSTERDAM — SGO, which makes the Mistika finishing ...

Treatment-related adverse events occurred in 31.6% and 26.1%, respectively ... and pelvic pain," noted SGO discussant Kristin Bixel, MD, of the Ohio State University Comprehensive Cancer Center ...